
Vælg din etiket
vises direkte på hætteglassetEloralintide
Amylin
- Sendes fra Tyskland
Bestilling
- DHL med sporing
- Diskret emballage
Kort fortalt
Eloralintide i tal
Nøgletallene fra vores leksikon. Træk punktet langs kurven for at se, hvor meget der er tilbage efter én dosis, beregnet.
Hele leksikonopslagetHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~14 days
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 13 to 15 days, we calculate with the middle.
Half-life
around13to15days
- Class
- Selective amylin receptor agonistprefers AMY1R
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 10 mg1 size in the shop
What studies show
All 4 sources in the lexiconAnmeldelser
Hvad kunderne siger
Kun rigtige bestillinger, der indeholdt Eloralintide.
Alle anmeldelserDer er endnu ingen laboratorieanalyse for Eloralintide. Stem på denFå det testet selv, vi betaler halvdelenAlle laboratorieanalyser
Viden
Alt om Eloralintide
Detaljerede oplysninger kommer snart.
Dosering
Indlæser doseringsinformation …
Godt at have
Det har du brug for til den
Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.
Insulinsprøjter
10 stk. · 5.50 €
Spritservietter
50 stk. · 10 €
Hvor meget vand?
Enheder på sprøjten til din hætteglasstørrelse.
Åbn beregneren →Is eloralintide approved?
No. As of 26 October 2026 ClinicalTrials.gov lists seven phase 3 trials: five ENLIGHTEN trials with eloralintide alone (recruiting since December 2025) and two AMPLIFY trials with a combination of eloralintide and tirzepatide. The AMPLIFY trials have not started yet. First main results are planned for 2028.
How does eloralintide differ from cagrilintide?
Mainly the receptor profile and the duration. In cell assays eloralintide activates the human amylin 1 receptor about twelve times more strongly than the calcitonin receptor, while cagrilintide acts on both. In rats eloralintide caused less taste aversion than cagrilintide. At 12.9 to 15.3 days the half-life is about twice as long.
What did the phase 2 trial show?
263 adults with obesity or overweight without diabetes received one of four fixed levels, one of two step-up schemes or placebo for 48 weeks. Weight fell by 9.4 to 20.1 percent depending on the level, by 0.4 percent on placebo. Depending on the group 53 to 91 in 100 participants lost at least 10 percent, 13 on placebo.
How long does eloralintide stay in the body?
After a single dose the half-life was 310 to 366 hours, so about two weeks. It reached its peak blood level only after three to five days. With weekly dosing the level therefore builds up over several weeks and falls just as slowly after stopping.
Which side effects were seen?
Nausea and fatigue, both strongly dose-dependent: in the two lowest levels nausea was at placebo level at 11 and 13 percent (14 percent), at the third level 64 percent. Headaches and injection site reactions came on top. In phase 1 four participants reported low mood, three of them at the highest level stopped.
What about the pulse and the heart?
In phase 1 resting pulse fell within the first week, at the highest level by 14.4 beats per minute after 12 weeks (placebo 3.4). There were no symptoms from a pulse that was too slow. A review sees this as a difference from GLP-1 agonists but stresses that no amylin analogue has had a cardiovascular outcomes trial.
Relateret
Relaterede produkter
Eloralintide